TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Acura Pharmaceuticals ( (ACUR) ) has issued an announcement.
On June 28, 2019, Acura Pharmaceuticals entered into a $6.0 million promissory note with John Schutte, which was later transferred to AD Pharma. By June 9, 2021, AD Pharma converted the note and accrued interest into 42,984,375 shares of Acura’s common stock. As of May 29, 2025, AD Pharma owns approximately 65% of Acura’s outstanding common stock, excluding a warrant for 10 million shares. The maturity date of a secured promissory note was extended to December 31, 2025, reflecting strategic financial adjustments.
More about Acura Pharmaceuticals
Average Trading Volume: 8,025
Technical Sentiment Signal: Sell
Current Market Cap: $1.32M
For detailed information about ACUR stock, go to TipRanks’ Stock Analysis page.